Results 71 to 80 of about 423 (145)

Experience with the use of undenatured type II collagen in patients with stage III knee osteoarthritis: a multicenter, prospective, double-blind, placebo-controlled, randomized trial

Терапевтический архив
Introduction. Current strategies for treating osteoarthritis (OA) are based on a multimodal approach that includes pharmacological and non-pharmacological methods.
Liudmila I. Alekseeva, Natalia G. Kashevarova, Elena A. Taskina, Ekaterina A. Strebkova, Tatiana A. Korotkova, Evgenia P. Sharapova, Natalya M. Savushkina, Aleksander M. Lila, Nadezhda A. Shostak, Irina I. Nesterovich, Viktoriia A. Dedkova, Vasiliy B. Vasilyuk, Natalia V. Egorova, Marina A. Leontyeva, Svetlana P. Yakupova, Irina B. Vinogradova, Valentina N. Sorotskaya, Larisa I. Shirokova, Alla V. Rudakova   +18 more
doaj   +1 more source

Evaluation of the Effects of Undenatured Type II Collagen (UC-II) as Compared to Robenacoxib on the Mobility Impairment Induced by Osteoarthritis in Dogs

Veterinary Sciences, 2019
Osteoarthritis (OA) is a chronic disease that requires a multimodal therapeutic approach. The aim of this study was to evaluate the effects of undenatured type II collagen (UC-II) as compared to robenacoxib in dogs affected by OA. Our hypothesis was that
Marzia Stabile, Rossella Samarelli, Paolo Trerotoli, Laura Fracassi, Luca Lacitignola, Antonio Crovace, Francesco Staffieri   +6 more
doaj   +1 more source

On the immunotropic effects of a new combined pharmaconutraceutical preparation in osteoarthritis

Современная ревматология
Osteoarthritis (OA) is one of the leading causes of disability in the world, but the efficacy and safety of its treatment remain extremely low.
I. V. Sarvilina, A. M. Lila, O. A. Gromova   +2 more
doaj   +1 more source

Efficacy, safety and prospects of using a combination of native type II collagen, methylsulfonylmethane, boswellic acids, vitamin C and vitamin D₃ in knee osteoarthritis: a resolution of the Expert panel

Терапевтический архив
A meeting of the Expert Council on September 9, 2023 considered the last challenges in the treatment of osteoarthritis (OA) including OA in comorbid patients.
Vadim I. Mazurov, Liudmila I. Alekseeva, Irina B. Belyaeva, Igor G. Belenkiy, Artem L. Burulev, Inna Z. Gaydukova, Elena V. Zonova, Oleg V. Kalyuzhin, Olga B. Nesmeyanova, Elvira N. Otteva, Evgeniy A. Trofimov   +10 more
doaj   +1 more source

DMOADs and DMARDs in the treatment of patients with joint and spine diseases

Фармакоэкономика
The data on the classification of drugs, which are prescribed for the treatment of patients with joint and spine diseases, such as osteoarthritis (OA) and rheumatoid arthritis (RA), are presented.
O. A. Shavlovskaya
doaj   +1 more source

Generalized osteoarthritis: ways to search effective pharmacotherapy

Лечащий Врач
Background. Osteoarthritis is a heterogeneous disease characterized by lesions of one or more joints, diversity of clinical features, and a large palette of biochemical and molecular characteristics, which together suggests the existence of multiple ...
I. N. Sarvilina, A. G. Nazarenko, T. B. Minasov, O. A. Gromova   +3 more
doaj   +1 more source

Oral Administration of Protease-Soluble Chicken Type II Collagen Ameliorates Anterior Cruciate Ligament Transection-Induced Osteoarthritis in Rats. [PDF]

Nutrients, 2023
Chen NF, Lin YY, Yao ZK, Tseng CC, Liu YW, Hung YP, Jean YH, Wen ZH.   +7 more
europepmc   +1 more source

Evidence-Based Use of Undenatured Type II Collagen in the Management of Osteoarthritis in the Indian Subcontinent and Southeast Asia: A Narrative Review and an Expert Opinion. [PDF]

Cureus
Prabhoo R, Patel S, Sardar I, Jangid S, Thirupathy RV, Roy R.   +5 more
europepmc   +1 more source

Efficacy of Combined <i>Hericium erinaceus</i> Mycelium and Undenatured Type II Collagen in Reducing Osteoarthritis Progression in a Preclinical Animal Model. [PDF]

Int J Med Sci
Lee KT, Hsu CJ, Chen LC, Lee LY, Chen WP, Chen YW, Chen CC, Lin YY, Chang TC, Su CM, Tang CH.   +10 more
europepmc   +1 more source

Bioactive Collagen Peptides in Veterinary and Biomedical Science-Part I: Molecular Identity, Gastrointestinal Bioavailability, and Receptor-Mediated Signaling, with Relevance to the Bile Acid Axis. [PDF]

Vet Sci
Németh K, Kis M, Mózes B, Schilling-Tóth BM, Jócsák G, Tóth I, Kiss DS, Lányi K, Csorba S, Bartha T.   +9 more
europepmc   +1 more source